These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences. DI Giuseppe G; Ciccarelli G; Cefalo CM; Cinti F; Moffa S; Impronta F; Capece U; Pontecorvi A; Giaccari A; Mezza T Minerva Endocrinol (Torino); 2021 Sep; 46(3):272-292. PubMed ID: 34218657 [TBL] [Abstract][Full Text] [Related]
5. Prediabetes in a nursing facility patient with renal insufficiency. Shane-McWhorter L Consult Pharm; 2010 Jun; 25 Suppl B():11-8. PubMed ID: 20726378 [TBL] [Abstract][Full Text] [Related]
6. Prediabetes: A Worldwide Epidemic. Edwards CM; Cusi K Endocrinol Metab Clin North Am; 2016 Dec; 45(4):751-764. PubMed ID: 27823603 [TBL] [Abstract][Full Text] [Related]
7. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Fonseca VA Clin Cornerstone; 2007; 8(2):10-8; discussion 19-20. PubMed ID: 18357952 [TBL] [Abstract][Full Text] [Related]
8. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction. Brannick B; Dagogo-Jack S Endocrinol Metab Clin North Am; 2018 Mar; 47(1):33-50. PubMed ID: 29407055 [TBL] [Abstract][Full Text] [Related]
9. Prediabetes: the importance of early identification and intervention. Hsueh WA; Orloski L; Wyne K Postgrad Med; 2010 Jul; 122(4):129-43. PubMed ID: 20675976 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance. Smith-Marsh D Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667 [TBL] [Abstract][Full Text] [Related]
11. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials. Yuen A; Sugeng Y; Weiland TJ; Jelinek GA Aust N Z J Public Health; 2010 Apr; 34(2):172-8. PubMed ID: 23331362 [TBL] [Abstract][Full Text] [Related]
12. Global status of diabetes prevention and prospects for action: A consensus statement. Ibrahim M; Tuomilehto J; Aschner P; Beseler L; Cahn A; Eckel RH; Fischl AH; Guthrie G; Hill JO; Kumwenda M; Leslie RD; Olson DE; Pozzilli P; Weber SL; Umpierrez GE Diabetes Metab Res Rev; 2018 Sep; 34(6):e3021. PubMed ID: 29757486 [TBL] [Abstract][Full Text] [Related]
18. Drug therapy in prediabetes. Mukhopadhyay P; Chowdhury S J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765 [TBL] [Abstract][Full Text] [Related]
19. Identification and treatment of prediabetes to prevent progression to type 2 diabetes. Fonseca VA Clin Cornerstone; 2008; 9(2):51-9; discussion 60-1. PubMed ID: 19410162 [TBL] [Abstract][Full Text] [Related]
20. Should the metabolic syndrome patient with prediabetes be offered pharmacotherapy? Sullivan SD; Ratner RE Curr Diab Rep; 2011 Apr; 11(2):91-8. PubMed ID: 21207204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]